Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)

Xiangxue Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	6,672	6,461	3,406	3,961	5,266	5,842
Market Cap Growth	-12.26%	89.71%	-14.02%	-24.79%	-9.85%	1.02%
Enterprise Value	9,170	9,128	6,159	6,816	9,064	9,617
Last Close Price	10.09	9.77	5.15	6.07	8.07	8.95
PE Ratio	-	-	-	-	-	59.36
Forward PE	-	11.93	11.93	11.93	11.93	11.93
PS Ratio	4.54	3.48	1.48	1.81	1.77	1.90
PB Ratio	6.07	4.49	1.47	1.46	1.40	1.38
P/TBV Ratio	-	437.03	4.23	3.47	3.20	3.07
P/FCF Ratio	109.43	-	16.42	-	-	-
P/OCF Ratio	81.76	355.48	12.93	17.42	20.45	22.72
EV/Sales Ratio	6.23	4.91	2.68	3.12	3.05	3.13
EV/EBITDA Ratio	-	-	21.82	113.06	72.50	21.51
EV/EBIT Ratio	-	-	123.98	-	-	30.84
EV/FCF Ratio	150.38	-	29.69	-	-	-
Debt / Equity Ratio	2.02	1.56	1.05	0.90	0.92	0.93
Debt / EBITDA Ratio	-	-	8.48	38.38	27.04	8.86
Debt / FCF Ratio	36.36	-	11.73	-	-	-
Asset Turnover	0.19	0.24	0.27	0.22	0.25	0.30
Inventory Turnover	3.28	3.86	3.54	2.69	2.78	2.62
Quick Ratio	0.18	0.19	0.19	0.18	0.28	0.39
Current Ratio	0.27	0.30	0.35	0.32	0.44	0.55
Return on Equity (ROE)	-62.41%	-45.91%	-15.96%	-15.58%	-16.45%	3.39%
Return on Assets (ROA)	-2.67%	-1.85%	0.37%	-1.09%	-0.12%	1.89%
Return on Invested Capital (ROIC)	-10.06%	-5.75%	1.03%	-2.96%	-0.31%	3.85%
Return on Capital Employed (ROCE)	-25.00%	-11.10%	1.60%	-5.10%	-0.50%	5.80%
Earnings Yield	-15.03%	-13.29%	-11.42%	-13.38%	-13.07%	1.69%
FCF Yield	0.91%	-0.26%	6.09%	-3.53%	-5.79%	-8.54%
Payout Ratio	-	-	-	-	-	208.23%
Buyback Yield / Dilution	-0.41%	-0.18%	0.50%	-0.09%	-0.89%	-2.90%
Total Shareholder Return	-0.41%	-0.18%	0.50%	-0.09%	-0.89%	-2.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.